A Phase 2, Randomized, Placebo-Controlled, Multiple Ascending-Dose Study of ACE-031, a Soluble Activin Receptor Type IIB, in Boys with Duchenne Muscular Dystrophy (DMD) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Campbell, Craig
  • Escolar, Diana
  • Mah, Jean
  • Tarnopolsky, Mark
  • Selby, Kathy
  • McMillan, Hugh
  • Yang, Yijun
  • Wilson, Dawn
  • Barger, Rachel
  • Sherman, Matthew
  • Attie, Kenneth

publication date

  • April 1, 2012